Real World Evidence of Long-term Safety and Efficacy in Patients Treated With Durvalumab After Concurrent Chemoradiation for Unresectable Stage III NSCLC

Research Site, Nagoya

Research Site, Toyoake

Research Site, Matsuyama

Research Site, Kurume

Research Site, Maebashi

Research Site, Asahikawa

Research Site, Sapporo

Research Site, Akashi

Research Site, Kobe

Research Site, Kasama

Research Site, Kanazawa

Research Site, Morioka

Research Site, Sagamihara

Research Site, Yokohama

Research Site, Matsubara

Research Site, Natori-shi

Research Site, Sendai

Research Site, Nishihara

Research Site, Hirakata

Research Site, Sakai

Research Site, Sayama

Research Site, Hidaka

Research Site, Izumo

Research Site, Mishima

Research Site, Mibu

Research Site, Shimotsuke

Research Site, Bunkyo

Research Site, Chūō

Research Site, Koto

Research Site, Mitaka

Research Site, Shinjuku

Research Site, Iwakuni

Research Site, Chiba

Research Site, Fukuoka

Research Site, Hiroshima

Research Site, Kyoto

Research Site, Nagasaki

Research Site, Niigata

Research Site, Okayama

Research Site, Osaka

Research Site, Saitama

Research Site, Tokushima

Research Site, Wakayama